<DOC>
	<DOCNO>NCT00421746</DOCNO>
	<brief_summary>The purpose study determine whether piboserod , serotonin-4 receptor antagonist , effective treatment patient congestive heart failure .</brief_summary>
	<brief_title>A Clinical Study Assessing Potential Piboserod Treatment Heart Failure</brief_title>
	<detailed_description>Despite intensive research decade , mortality morbidity chronic heart failure remain quite high . There obvious need new drug , especially drug may different mode action exist one market . The purpose trial evaluate whether new drug candidate , piboserod , beneficial biological effect stable outpatient symptomatic heart failure receive evidence base treatment heart failure ass safety tolerability treatment .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Clinical diagnosis CHF ( NYHA class IIIV ) Locally determine LVEF &lt; 0.35 ( CMR , echocardiography , LV angiography , radionuclide cardioangiography ) Stable sinus rhythm Stable evidence base pharmacological treatment CHF . Unstable patient hospitalise within last 2 week Baseline prolongation QTc interval Atrial fibrillation randomisation MI revascularisation last 3 month Stroke last 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>